Significant increase of self-renewal in hematopoietic cells after forced expression of EVI1
- PMID: 17913523
- PMCID: PMC2323624
- DOI: 10.1016/j.bcmd.2007.07.012
Significant increase of self-renewal in hematopoietic cells after forced expression of EVI1
Abstract
EVI1 was first identified as a preferential integration site of ecotropic retroviruses in the MDS1/EVI1 genomic locus leading to myeloid tumors in susceptible mice. Later studies showed that retroviral integration in the MDS1/EVI1 locus results in the emergence of a non-malignant dominant hematopoietic stem cell clone in non-susceptible mice strains, in non-human primates, and in patients, suggesting that a gene encoded by the locus could affect the self-renewal potential of a cell. The locus encodes two genes. One of them, EVI1, has long been associated with myeloid leukemia. To understand whether EVI1 has a role in self-renewal control, we forcibly expressed EVI1 in the bone marrow progenitors of two mice strains that differ in their proliferation and self-renewal potential. By comparing the response of the hematopoietic cells to EVI1, we conclude that EVI1 has a role in prolonging the self-renewal potential of the cells and that this ability of EVI1 is limited and modulated by inherent characteristics of the cells.
Figures
Similar articles
-
Evi1 is essential for hematopoietic stem cell self-renewal, and its expression marks hematopoietic cells with long-term multilineage repopulating activity.J Exp Med. 2011 Nov 21;208(12):2403-16. doi: 10.1084/jem.20110447. Epub 2011 Nov 14. J Exp Med. 2011. PMID: 22084405 Free PMC article.
-
Recurrent retroviral vector integration at the Mds1/Evi1 locus in nonhuman primate hematopoietic cells.Blood. 2005 Oct 1;106(7):2530-3. doi: 10.1182/blood-2005-03-1115. Epub 2005 Jun 2. Blood. 2005. PMID: 15933056 Free PMC article.
-
Forced expression of the leukemia-associated gene EVI1 in ES cells: a model for myeloid leukemia with 3q26 rearrangements.Leukemia. 1999 Nov;13(11):1639-45. doi: 10.1038/sj.leu.2401585. Leukemia. 1999. PMID: 10557037
-
The role of EVI1 in normal and leukemic cells.Blood Cells Mol Dis. 2003 Sep-Oct;31(2):206-12. doi: 10.1016/s1079-9796(03)00159-1. Blood Cells Mol Dis. 2003. PMID: 12972028 Review.
-
Ecotropic viral integration site 1, stem cell self-renewal and leukemogenesis.Cancer Sci. 2012 Aug;103(8):1371-7. doi: 10.1111/j.1349-7006.2012.02303.x. Epub 2012 May 18. Cancer Sci. 2012. PMID: 22494115 Free PMC article. Review.
Cited by
-
EVI1-mediated Programming of Normal and Malignant Hematopoiesis.Hemasphere. 2023 Oct 4;7(10):e959. doi: 10.1097/HS9.0000000000000959. eCollection 2023 Oct. Hemasphere. 2023. PMID: 37810550 Free PMC article. Review.
-
EVI1 and MDS1/EVI1 expression during primary human hematopoietic progenitor cell differentiation into various myeloid lineages.Anticancer Res. 2012 Nov;32(11):4883-9. Anticancer Res. 2012. PMID: 23155256 Free PMC article.
-
EVI1 is critical for the pathogenesis of a subset of MLL-AF9-rearranged AMLs.Blood. 2012 Jun 14;119(24):5838-49. doi: 10.1182/blood-2011-11-393827. Epub 2012 May 2. Blood. 2012. PMID: 22553314 Free PMC article.
-
Prognostic Value of EVI1 Expression in Pediatric Acute Myeloid Leukemia: A Systematic Review.Iran J Pathol. 2018 Summer;13(3):294-300. Epub 2018 Sep 12. Iran J Pathol. 2018. PMID: 30636951 Free PMC article. Review.
-
CRISPR Gene Editing of Murine Blood Stem and Progenitor Cells Induces MLL-AF9 Chromosomal Translocation and MLL-AF9 Leukaemogenesis.Int J Mol Sci. 2020 Jun 15;21(12):4266. doi: 10.3390/ijms21124266. Int J Mol Sci. 2020. PMID: 32549410 Free PMC article.
References
-
- Perkins AS, Mercer JA, Jenkins NA, Copeland NG. Patterns of Evi-1 expression in embryonic and adult tissues suggest that Evi-1 plays an important regulatory role in mouse development. Development. 1991;111:479. - PubMed
-
- Kustikova O, Fehse B, Modlich U, Yang M, Düllmann J, Kamino K, von Neuhoff N, Schlegelberger B, Li Z, Baum C. Clonal dominance of hematopoietic stem cells triggered by retroviral gene marking. Science. 2005;308:1171–74. - PubMed
-
- Ott MG, Schmidt M, Schwarzwaelder K, Stein S, Siler U, Koehl U, Glimm H, Kühlcke K, Schilz A, Kunkel H, Naundorf S, Brinkmann A, Deichmann A, Fischer M, Ball C, Pilz I, Dunbar C, Du Y, Jenkins NA, Copeland NG, Lüthi U, Hassan M, Thrasher AJ, Hoelzer D, von Kalle C, Seger R, Grez M. Correction of X-linked chronic granulomatous disease by gene therapy, augmented by insertional activation of MDS1-EVI1, PRDM16 or SETBP1. Nat Med. 2006;12:401–9. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical